UC Medical Center to Honor Developer of Polio Vaccine with Ohio Historical Marker
The UC Medical Center will honor the accomplishments of Albert B. Sabin, MD, with the dedication of an Ohio Historical Marker on Thursday, June 19 at 4 p.m. at the entrance to the Vontz Center for Molecular Studies, UC Medical Center. Dr. Sabin was a faculty member of the UC College of Medicine and Cincinnati Children's Hospital Research Foundation (CHRF) when he developed the live-virus polio vaccine in 1960.
The marker, sponsored by the Ohio Historical Society to celebrate the Ohio Bicentennial, will be placed in front of the Vontz Center at the corner of Martin Luther King Drive and Eden Avenue. The marker complements the permanent display of Dr. Sabin's work housed in the lobby of the Vontz Center.
To date, there are 43 Ohio Historical Markers in Hamilton County alone. The Ohio Bicentennial Commission was formed in 1995 to promote and plan for Ohio's 200th birthday in 2003. Since its inception, the Ohio Bicentennial Commission has spearheaded two programs that have generated more than 500 new historical markers in the state of Ohio.
Guests of honor at the event include Dr. Sabin's widow, Heloisa Sabin, from Washington D.C.; Jack Blosser of the Ohio Historical Society; Thomas F. Boat, MD, chair of the Department of Pediatrics at the UC College of Medicine, director of CHRF and interim provost for Health Affairs at the UC Medical Center; and William J. Martin II, MD, dean of the UC College of Medicine and acting Senior Vice President of the UC Medical Center.
Related Stories
Why can it get so hot at times?
September 3, 2026
Cincinnati is experiencing more days of extreme heat this summer than in previous decades, due in large part to warmer global temperatures. But explanations for these higher temperatures also relate to regional factors, including the city's location in a river valley and large proportion of built environment.
UC invests in the next generation of graduate leaders through fellowships focused on mentorship and research
September 3, 2026
The Next Lives Here Presidential Fellowship supports the recruitment of top doctoral students through competitive funding, mentorship and professional development.
Cancer Center plays key role in lab research, clinical trials for new pancreatic cancer drug
September 1, 2026
WLWT and WCPO highlighted the contributions of University of Cincinnati Cancer Center researchers that helped lead to the recent FDA approval of daraxonrasib, a new treatment for pancreatic cancer.